That’s what researchers at the State Hospital for Cardiology in Hungary reported in the Journal of Cardiovascular Pharmacology in August 2006.

As you may already know, current medical opinion is that aspirin inhibits blood clots and reduces the risk of death from heart attack and stroke. Aspirin benefits a lot of people with coronary artery disease and atherosclerosis or hardening of the arteries. It’s prescribed to those who have had a heart attack.

Aspirin works by preventing blood platelets from clumping together to form a blood clot. This process is regulated by chemicals that are known as prostaglandins. Just like you have good cholesterol and bad cholesterol or good carbs and bad carbs, you also have good prostaglandins and bad prostaglandins in the body. The good prostaglandins keep inflammation and clotting to a minimum. The bad prostaglandins trigger events that cause clotting and inflammation. Aspirin keeps the blood free-flowing, thus reducing the risk of clots.

Hungarian researchers found that high-risk cardiovascular patients can still suffer a serious vascular event (heart attack or stroke) even though they are on aspirin. The aspirin fails to stop the platelets from clumping together to form the clot in 1 out of every 5 incidents related to heart disease for this high risk group of people.

Now imagine if you are a patient with heart disease. How would you know if you are in that 20% or not? There’s no way that your friendly clinical laboratory or doctor’s office will be able to predict this. However, in research, this is measured by platelet clumping found in the blood after epinephrine or collagen is added to the blood of a person taking aspirin.

How could people predict dying from a heart attack or stroke if they were in the aspirin failure group? That thought was enough to stimulate researchers to try to solve the problem. They knew that Resveratrol had the ability to inhibit platelet clumping (aggregation) in animals. They decided to test it in humans. Those that had the highest aggregation rate were also high on the scale for aspirin failure.

And here’s the part where Resveratrol came to the rescue. Researchers found that they could influence what was happening by adding Resveratrol to the diet. Resveratrol worked best in the cases where the platelet clumping from collagen and epinephrine were at a maximal level; i.e., those who were aspirin resistant. Researchers concluded that the heart-protective effects of Resveratrol could be due to this blood clot preventative activity.

As someone with a family history of heart disease, I’m glad that Vinomis has done all the work necessary to create a great Resveratrol supplement. The Vindure 900 contains more Resveratrol than any other company on the market.

Filed under: resveratrol